You have 9 free searches left this month | to do more

evogliptin

Evogliptin is a drug used to treat Diabetes Mellitus, Type 2, Type2 Diabetes, Albuminuria, and other conditions. Evogliptin is being actively studied in 3 studies and prior, has been studied in 6.

Top SponsorsTop SitesTop Investigators
Dong-A ST Co., Ltd.Samsung Medical CenterJae Hyeon Kim, MD, PhD
Asan Medical CenterAsan Medical CenterJae-Kwan Song
DongGuk UniversityCCBR Brasil Centro de Pesquisas e Analises Clinicas LtdaNamyi Gu
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
R
Not yet recruiting
  • Calcific Aortic Valve Disease
  • Evogliptin
  • Placebo
  • (no location specified)
2021-11-19
Nov 19, 2021
D
Unknown status
  • Diabetes Mellitus, Type 2
  • Evogliptin
  • Metformin and Evogliptin
  • Seoul, Nowon-gu, Korea, Republic of
    Sanggye paik pospital
2021-02-15
Feb 15, 2021
K
Not yet recruiting
  • Bone Diseases, Metabolic
  • Diabetes Mellitus, Type 2
  • Gangneung, Gangwondo, Korea, Republic of
  • +6 more
2021-01-10
Jan 10, 2021
A
Not yet recruiting
  • CAVD
  • Evogliptin
  • Seoul, Korea, Republic of
    Asan Medical Center
2020-08-19
Aug 19, 2020
D
Completed
  • Type2 Diabetes
  • Non-Alcoholic Fatty Liver Disease
  • Changwon, Korea, Republic of
  • +6 more
2021-04-27
Apr 27, 2021
S
Completed
  • Type2 Diabetes Mellitus
  • +2 more
  • Seoul, Korea, Republic of
    Samsung Medical Center
2019-09-19
Sep 19, 2019
D
Completed
  • Type2 Diabetes
  • Seoul, Korea, Republic of
    Division of Endocrinology and Metabolism, Department of Internal
2018-07-19
Jul 19, 2018
E
Completed
  • Diabetes Mellitus, Type 2
  • Evogliptin
  • +3 more
  • Fortaleza, Cear√°, Brazil
  • +9 more
2018-08-12
Aug 12, 2018
D
Completed
  • Liver Dysfunction
  • Evogliptin
  • Seoul, Korea, Republic of
    Severance Hospital Clinical Trial Center
2018-02-23
Feb 23, 2018
D
Completed
  • Type 2 Diabetes Mellitus
  • Seoul, Korea, Republic of
    Kangbuk Samsung Medical Center
2016-10-27
Oct 27, 2016
D
Unknown status
  • Diabetes Mellitus, Type 2
  • Osteoporosis
  • Evogliptin
  • Goyang, Gyeonggi, Korea, Republic of
    Dongguk University Ilsan Hospital
2016-07-21
Jul 21, 2016